Chronic Lymphocytic Leukemia (CLL) Prognostic Panel, Comprehensive
Test Code
Clinical Significance
Chronic Lymphocytic Leukemia (CLL) Prognostic Panel, Comprehensive - Chronic Lymphocytic leukemia is the most common leukemia in the Western world. The disease is chronic and most patients may not require therapy in the early stage of the disease. However, in some patients the disease can be aggressive and within a year the tumor mass may increase significantly imposing serious health problems to the patient. It is difficult to determine based on clinical presentation which patient will progress faster than the others. Therefore, there is a need to use more accurate prognostic indicator to predict the clinical course of this disease. The recent advances in CLL therapy and biology made it possible to develop new tests and a combination of these tests.
Test Resources
Test Details
Chromosome Analysis, CLL/LPD
Chronic Lymphocytic Leukemia, IgVH Mutation Status
CD38+ CLL cells
FISH, B-Cell Chronic Lymphocytic Leukemia Panel
ZAP-70
Methodology
Reference Range(s)
Preferred Specimen(s)
5 mL whole blood collected in an EDTA (lavender-top) tube and
16 mL whole blood collected in a sodium heparin (green-top) tube and
1 mL serum
Minimum Volume
3 mL EDTA whole blood • 10 mL sodium heparin whole blood • 0.5 mL serum
Collection Instructions
See individual tests
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 72 hours
- Refrigerated: Unacceptable
- Frozen: Unacceptable
Reject Criteria
Hemolysis • Lipemia
Setup Schedule
16 mL whole blood collected in a sodium heparin (green-top) tube and
1 mL serum
Refrigerated: Unacceptable
Frozen: Unacceptable